EUVIMEDEUVIMED entdecken
Crossref

From Discard to Discovery: Leveraging Residual Cytology Fine-Needle Aspiration Supernatants for Rapid EGFR and KRAS Mutation Detection in Lung Cancer

Margaret Parham, Saroja Devi Geetha, David E Ost, Sravanthi Lavu, Gloria Hopkins Sura

Acta Cytologica · 02.05.2026 · 1-10

DOI: 10.1159/000552356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Cytologica, online erschienen am 02.05.2026. Verfasst von Margaret Parham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of the Molecular Diagnostic Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas…. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Timely molecular testing is essential for guiding targeted therapy in non-small cell lung cancer (NSCLC), yet results are often delayed by limited tissue availability and reliance on formalin-fixed, paraffin-embedded (FFPE) material for next-generation sequencing (NGS). Cytology fine-needle aspiration specimens frequently provide the sole diagnostic sample, and their residual supernatants – typically discarded – represent an untapped source of tumor-derived nucleic acids.

Methods

In this pilot study, cytology supernatants from 10 NSCLC cases with known EGFR or KRAS mutations by NGS were analyzed using Idylla™ ctEGFR and ctKRAS Mutation Assays. Each 2–3 mL supernatant sample, stored in CytoLyt® at 4°C after cell block preparation, was tested without extraction. Idylla™ results were compared with orthogonal NGS data for concordance, and turnaround times for routine FFPE-based testing were evaluated to model potential workflow improvements.

Results

All four EGFR-mutated cases (p.L858R, p.G719A, and exon 19 deletions) were correctly detected by Idylla™, yielding 100% concordance with NGS. Among six KRAS-mutated cases, Idylla™ identified all p.G12C variants but missed p.G12V and p.Q61K, achieving 80% overall concordance. Median time from collection to NGS report was 22 days, whereas modeled same-day Idylla™ testing offered a theoretical reduction of approximately 20 days in turnaround time. Discordant cases correlated with relatively low tumor cellularity in cell blocks.

Conclusion

Cytology supernatants preserved in CytoLyt® are a feasible substrate for rapid, cartridge-based molecular testing using the Idylla™ platform. This approach can serve as a complementary or rescue strategy when cellular slide preparations or FFPE tissue is limited or NGS fails, enabling faster access to actionable molecular results in NSCLC.

Schlagwörter

Stichwörter der Autor:innen

Cytology fine-needle aspiration supernatantsIdylla™Lung cancerNext-generation sequencingRapid EGFR and KRAS mutation detectionRapid molecular testing

Autor:innen und Institutionen

  • Section of the Molecular Diagnostic Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Section of Cytopathology, Department of Anatomic Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Pulmonary Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sections of Cytopathology and the Molecular Diagnostic Laboratory, Department of Anatomic Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA,…

Zitieren

APA

Parham, M., Geetha, S. D., Ost, D. E., Lavu, S., & Sura, G. H. (2026). From Discard to Discovery: Leveraging Residual Cytology Fine-Needle Aspiration Supernatants for Rapid EGFR and KRAS Mutation Detection in Lung Cancer. Acta Cytologica, 1-10. https://doi.org/10.1159/000552356

Vancouver

Parham M, Geetha SD, Ost DE, Lavu S, Sura GH. From Discard to Discovery: Leveraging Residual Cytology Fine-Needle Aspiration Supernatants for Rapid EGFR and KRAS Mutation Detection in Lung Cancer. Acta Cytologica. 2026:1-10. doi:10.1159/000552356

BibTeX
@article{Parham2026,
  author = {Parham, Margaret and Geetha, Saroja Devi and Ost, David E and Lavu, Sravanthi and Sura, Gloria Hopkins},
  title = {From Discard to Discovery: Leveraging Residual Cytology Fine-Needle Aspiration Supernatants for Rapid EGFR and KRAS Mutation Detection in Lung Cancer},
  journal = {Acta Cytologica},
  year = {2026},
  pages = {1--10},
  doi = {10.1159/000552356}
}
Kostenlos starten →